These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16258020)

  • 21. Ligand-Free Signaling of G-Protein-Coupled Receptors: Relevance to μ Opioid Receptors in Analgesia and Addiction.
    Sadee W; McKew JC
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferential Delivery of an Opioid Antagonist to the Fetal Brain in Pregnant Mice.
    Oberdick J; Ling Y; Phelps MA; Yudovich MS; Schilling K; Sadee W
    J Pharmacol Exp Ther; 2016 Jul; 358(1):22-30. PubMed ID: 27189967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Drug Monitoring of Naltrexone and 6β-Naltrexol During Anti-craving Treatment in Alcohol Dependence: Reference Ranges.
    Brünen S; Bekier NK; Hiemke C; Korf F; Wiedemann K; Jahn H; Kiefer F
    Alcohol Alcohol; 2019 Jan; 54(1):51-55. PubMed ID: 30260366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics and inhibition of the formation of 6beta-naltrexol from naltrexone in human liver cytosol.
    Porter SJ; Somogyi AA; White JM
    Br J Clin Pharmacol; 2000 Nov; 50(5):465-71. PubMed ID: 11069441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naltrexone metabolism and concomitant drug concentrations in chronic pain patients.
    Liu JC; Ma JD; Morello CM; Atayee RS; Best BM
    J Anal Toxicol; 2014 May; 38(4):212-7. PubMed ID: 24659754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists.
    Yuan Y; Li G; He H; Stevens DL; Kozak P; Scoggins KL; Mitra P; Gerk PM; Selley DE; Dewey WL; Zhang Y
    ACS Chem Neurosci; 2011 Jul; 2(7):346-51. PubMed ID: 22816021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of Receptor Theory to the Design and Use of Fixed-Proportion Mu-Opioid Agonist and Antagonist Mixtures in Rhesus Monkeys.
    Cornelissen JC; Obeng S; Rice KC; Zhang Y; Negus SS; Banks ML
    J Pharmacol Exp Ther; 2018 Apr; 365(1):37-47. PubMed ID: 29330156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists.
    Valentino RJ; Katz JL; Medzihradsky F; Woods JH
    Life Sci; 1983 Jun; 32(25):2887-96. PubMed ID: 6304445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An efficient synthesis of 3-OBn-6β,14-epoxy-bridged opiates from naltrexone and identification of a related dual MOR inverse agonist/KOR agonist.
    Martin DJ; FitzMorris PE; Li B; Ayestas M; Sally EJ; Dersch CM; Rothman RB; Deveau AM
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6801-5. PubMed ID: 22771010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 6β-N-Heterocyclic Substituted Naltrexamine Derivative BNAP: A Peripherally Selective Mixed MOR/KOR Ligand.
    Williams DA; Zheng Y; David BG; Yuan Y; Zaidi SA; Stevens DL; Scoggins KL; Selley DE; Dewey WL; Akbarali HI; Zhang Y
    ACS Chem Neurosci; 2016 Aug; 7(8):1120-9. PubMed ID: 27269866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative efficacy of buprenorphine, nalbuphine and morphine in opioid-treated rhesus monkeys discriminating naltrexone.
    Sell SL; McMahon LR; France CP
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1167-73. PubMed ID: 12766254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
    Zernig G; Butelman ER; Lewis JW; Walker EA; Woods JH
    J Pharmacol Exp Ther; 1994 Apr; 269(1):57-65. PubMed ID: 8169852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects.
    Weerts EM; Kim YK; Wand GS; Dannals RF; Lee JS; Frost JJ; McCaul ME
    Neuropsychopharmacology; 2008 Feb; 33(3):653-65. PubMed ID: 17487229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of beta-funaltrexamine (beta-FNA) on morphine dependence in rats and monkeys.
    Aceto MD; Dewey WL; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1986 Apr; 123(3):387-93. PubMed ID: 3720824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers.
    McCaul ME; Wand GS; Rohde C; Lee SM
    Alcohol Clin Exp Res; 2000 Sep; 24(9):1385-91. PubMed ID: 11003204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
    Holtzman SG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
    Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 6-beta-naltrexol reduces alcohol consumption in rats.
    Rukstalis MR; Stromberg MF; O'Brien CP; Volpicelli JR
    Alcohol Clin Exp Res; 2000 Oct; 24(10):1593-6. PubMed ID: 11045869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antagonist-precipitated and discontinuation-induced withdrawal in morphine-dependent rhesus monkeys.
    Becker GL; Gerak LR; Koek W; France CP
    Psychopharmacology (Berl); 2008 Dec; 201(3):373-82. PubMed ID: 18726088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.